TJ Cradick

Company: HuidaGene Therapeutics

Job title: Chief Technology Officer

Seminars:

Characterizing Novel CRISPR Editors for Next-Generation Therapeutics 2:00 pm

Developing Assays for Protein Engineering and Therapeutic Development Novel assays for novel editors to establish data sets for regulatory filingsRead more

day: Conference Day One

Strategies for the Analytical Development of CRISPR-Based Therapies in Rare & Ultra-Rare Diseases 1:30 pm

This workshop will explore the unique analytical development challenges and strategic considerations involved in advancing CRISPR-based therapies for rare and ultra-rare diseases. Using the recent case of the first-ever personalized CRISPR medicine as a foundation, the session will examine how analytical teams can respond to accelerated timelines, limited patient populations, and evolving regulatory expectations. Attendees…Read more

day: Pre-Conference Day